Neurocrine Biosciences (NBIX) had the lowest return in 2006 by a large-cap US stock, returning -83.6%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Neurocrine Biosciences (NBIX) | 2006 | -83.55% |
Insmed (INSM) | 2006 | -55.56% |
Sirius XM (SIRI) | 2006 | -48.02% |
QXO (QXO) | 2006 | -42.86% |
Leonardo DRS, Inc Common Stock (DRS) | 2006 | -38.18% |
Jabil Circuit (JBL) | 2006 | -34.54% |
Advanced Micro Devices (AMD) | 2006 | -34.4% |
DexCom (DXCM) | 2006 | -34.22% |
Marvell Technology (MRVL) | 2006 | -32.32% |
eBay (EBAY) | 2006 | -31.21% |
Boston Scientific (BSX) | 2006 | -30.05% |
Vicor (VICR) | 2006 | -29.45% |
Teva Pharma Industries Ltd ADR (TEVA) | 2006 | -29.43% |
Semtech (SMTC) | 2006 | -29.01% |
Onto Innovation (ONTO) | 2006 | -27.89% |
Williams-Sonoma (WSM) | 2006 | -27.21% |
Celestica (CLS) | 2006 | -26.74% |
DR Horton (DHI) | 2006 | -25.92% |
Monolithic Power Systems (MPWR) | 2006 | -24.68% |
Cheniere Energy (LNG) | 2006 | -22.45% |
Modine Manufacturing (MOD) | 2006 | -21.44% |
United Therapeutics (UTHR) | 2006 | -21.41% |
Watsco (WSO.B) | 2006 | -20.92% |
Watsco (WSO) | 2006 | -20.55% |
Cognex (CGNX) | 2006 | -20.41% |
Large-cap stocks are treated as having a market cap of $10B+.